1. 220PSefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study. (23rd October 2018) Authors: Jacquin, J-P P; Uwer, L; Savignoni, A; Ferrero, J-M; Lortholary, A; Solub, D; Attar-Rabia, H; Deblay, S; Pibre, S; Belkacemi, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗